Dr. Demehri and his team enrolled 18 patients to evaluate the mechanism behind a topical immunotherapy treatment on precancerous skin lesions. Here are five notes from the study: The topical ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first ...

Study: T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions. Image Credit ... driving research into new protective treatments. One promising approach is topical ...

I recently submitted to a treatment aimed at correcting the ... is highly efficient for treating precancerous skin lesions, certain cancerous lesions (superficial, nonmelanoma skin cancer ...

Our skin cancer experts are experienced in helping people make a treatment decision they are ... which destroy the precancerous cells. Another option for small, low-risk lesions is topical ...

A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer ...

A small study of 18 patients with skin cancer found that the combination of vitamin D and chemotherapy provided an immune ...

Eighteen patients with qualifying precancerous skin lesions were enrolled. Participants applied a treatment of 0.0025% calcipotriol and 2.5% 5-FU to affected areas - including the face ...

The best tactics for dealing with gastric cancer is prevention, early detection and early treatment ... with early gastric cancers and precancerous gastric lesions, without the need for surgery.

Eighteen patients with qualifying precancerous skin lesions were enrolled. Participants applied a treatment of 0.0025% calcipotriol and 2.5% 5-FU to affected areas—including the face ...

Eighteen patients with qualifying precancerous skin lesions were enrolled. Participants applied a treatment of 0.0025% calcipotriol and 2.5% 5-FU to affected areas -- including the face ...

Eighteen patients with qualifying precancerous skin lesions were enrolled. Participants applied a treatment of 0.0025% calcipotriol and 2.5% 5-FU to affected areas—including the face ...